Literature DB >> 23342982

Alternative approach for mitigation of doxorubicin-induced cardiotoxicity using herbal agents.

Mohammad Ahmed Khan, Mhaveer Singh, Masood Shah Khan, Wasim Ahmad, Abul Kalam Najmi, Sayeed Ahmad1.   

Abstract

Doxorubicin (DOX) is an effective and frequently used chemotherapeutic agent for various malignancies. However, its clinical use is hampered due to the development of cardiotoxicity. Investigations have proved that DOX-induced cardiotoxicity occurs through mechanisms other than those mediating its antitumor effect. This theory sheds light on the development of strategies for cardioprotection without altering therapeutic effectiveness of DOX. Bioactive plant constituents of dietary supplements, traditional herbs and foods with potential health benefits can play an important role in therapeutics. This manuscript is an exhaustive review and prospect of herbal and botanical agents against DOX-induced cardiotoxicity with their proposed mechanisms. The activity of herbs evaluated against DOX-induced cardiotoxicity has shown number of mechanisms including apoptosis, antioxidant potential, effect on mitochondria and calcium ion regulation etc. The manuscript reveals that most of the herbal drugs studied are effective through antioxidant mechanism and only few through other major pathways such as apoptosis and iron mediated pathways in DOX-induced cardiotoxicity. Only limited reports are available for the prevention of DOX-induced drug resistance using botanicals. Manuscript reports a number of constituents with evident potential in prevention of DOX cardiotoxicity e.g. proanthocyanidins, epigallocatechin-3-gallate, S-allylcysteine, reseveratrol, rutoside etc. In the present communication, several herbal drugs have also been discussed, which can act through mechanisms other than antioxidant and may be evaluated as a combination therapy for prevention of DOX-induced cardiotoxicity in future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23342982     DOI: 10.2174/1574884709999140606162053

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  4 in total

1.  Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a.

Authors:  Zhan Sun; Bin Yan; Wen Yan Yu; Xueping Yao; Xiaojuan Ma; Geli Sheng; Qi Ma
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

2.  Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo.

Authors:  Junqing Gao; Tao Chen; Deqiang Zhao; Jianpu Zheng; Zongjun Liu
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

3.  Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.

Authors:  Kamran Harati; Björn Behr; Christoph Wallner; Adrien Daigeler; Tobias Hirsch; Frank Jacobsen; Marcus Renner; Ali Harati; Marcus Lehnhardt; Mustafa Becerikli
Journal:  Mol Med Rep       Date:  2016-11-28       Impact factor: 2.952

4.  Scientific validation of cardioprotective attribute by standardized extract of Bombyx mori against doxorubicin-induced cardiotoxicity in murine model.

Authors:  Masood S Khan; Mhaveer Singh; Mohammad A Khan; D S Arya; Sayeed Ahmad
Journal:  EXCLI J       Date:  2014-09-05       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.